Abstract:
Background: Substantial number of patients with paucibacillary leprosy may still have
active skin lesions at the end of MD treatment because of the continuing immune
responses, though this does not denote failure of treatment. A clinical trial was
conducted to compare efficacy of a homoeopathic medicine with MDT for the cure of
leprosy.
Aim: To compare the effect of a homoeopathic medicine – Sulphur with the Multi drug
in the treatment of Paucibacillary leprosy according to WHO guidelines.
Materials and Methods: Out of total 90 patients enlisted, 60 confirmed Borderline
Tuberculoid (BT) leprosy patients of the age 14 years to less than 60 years were
registered under this trial. All the patients were allotted a precoded number, randomly
and equally divided in two groups. One group was treated with Sulphur in 200 potency in
liquid orally once in week for two years and the other group received Paucibacillary (PB)
regimen as recommended by WHO. At the end of two years findings were corroborated.
Results: The study showed that MDT therapy (PB regimen) and homoeopathic medicine
were found equally effective as histopathology of skin showed no granulomatous
lesion. The most significant clinical sign observed in all cases treated with Sulphur was
reappearance of normal skin colour and regain of loss of sensation of the skin lesion.
Conclusions: MD therapy (PB regimen) and homoeopathic medicine were found
equally effective. The patients of paucibacillary leprosy could get rid of the skin
symptoms if treatment with Sulphur (is also given with MDT).
